Pembrolizumab and Carboplatin in Treating Patients With Relapsed or Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Clinical trial NCT03029598 · COMPLETED

Trial details

NCT number: NCT03029598
Sponsor: University of Washington
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Recurrent Fallopian Tube Carcinoma Recurrent Ovarian Carcinoma Recurrent Primary Peritoneal Carcinoma

Start date: 2017-03-14
Primary completion: 2021-04-20
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.